AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports Reuters

March 7, 2026 at 01:04 AM Original source
2 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
1 articles
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

C
Carlos MéndezJournalist

Carlos Méndez is a journalist reporting from Mexico City.

Locations

denmark Mexico City, Mexico USA

Tags

business partnership drugs feud health healthcare hims novo obesity obesity drugs partnership pharmaceuticals weight loss

All Coverage

Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNdXNlT2JONFFqbVlvbHRJQlRZQkc4MXFjcGlobnVyYklCZzlKdnpQMkYtaUp4enVqVGNUTjZ6SWJMLW5XWjB2Wk1YZ2tMTm42Mi1pVDVYcUI4ZGRRTkJ3bWtETmxWejNHd3pqbWVjMUxMN3JCM05aa1ZoTkszNEdMUXZYc202Uk80QzFkcUNyZVJjM2ZLM01uZDNHeTlZTXlXOEFmS2Q2WWc2OG5KR3Q5M3pyQVpCYTd5M3JwclZUMVlNSE1ZeHJXc1pEelpoQ2xaQ2Rxbl9wa2pOeTM2ZFE?oc=5" target="_blank">Novo and Hims to sell obesity drugs together as feud ends, Bloomberg News reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%
Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports
Yahoo! Newsvia ai

Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health platform, ending a dispute that escalated into a legal battle last month.

80%

Similar Stories

Related coverage based on topic and tags

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters

WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters

October 7, 2026 at 07:39 AM

US FDA expands use of Novartis drug for chronic skin condition - Reuters

US FDA expands use of Novartis drug for chronic skin condition Reuters

October 7, 2026 at 04:51 PM

Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters

Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters

October 8, 2026 at 06:18 PM

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters

Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters

October 8, 2026 at 02:39 PM

US FDA flags four deaths in Newron's schizophrenia drug studies - Reuters

US FDA flags four deaths in Newron's schizophrenia drug studies Reuters

October 8, 2026 at 05:47 PM

PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies - Reuters

PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies Reuters

October 7, 2026 at 11:36 AM